Cephalon Will Pursue New Gabitril Uses After Acquisition Of Anti-Epileptic
Cephalon plans to develop Gabitril for indications outside of epilepsy, the company said after announcing the acquisition of the product from Abbott Nov. 1.
Cephalon plans to develop Gabitril for indications outside of epilepsy, the company said after announcing the acquisition of the product from Abbott Nov. 1.